Aim: To comparatively study the pharmacological profiles of 3-methyl-3-azabicyclo (3,3,1)nonanyl-9-α-yl-α-cyclopentyl-α-phenyl-α-glycolate (phencynonate hydrochloride, CPG), an anticholinergic agent, and its enantiomers [R(-)-and S(+)-CPG]. Methods: The affinity and relative efficacy were tested using radioligand-binding assay with muscarinic acetylcholine receptors from rat cerebral cortex. The pharmacological activities were assessed in three individual experiments: (1) potentiating the effect of subthreshold hypnotic dose of sodium pentobarbital; (2) inhibiting oxotremorine-induced salivation; and (3) inhibiting the contractile response to carbachol. Results: The order of potency of phencynonate hydrochloride and its optical isomers to inhibit the binding of
Introduction
Molecular handedness is a crucial structural feature of biologically active compounds, since opposite configurations at pharmacophoric groups frequently influence the biological response, mainly in terms of affinity, toxicity, and receptor subtype selectivity [1] . Therefore, the stereoisomeric composition of drugs is currently receiving considerable attention owing to its pharmacological as well as industrial and regulatory implications [2, 3] .
3-Methyl-3-azabicyclo(3,3,1)nonanyl-9-α-yl-α-cyclopentyl-α-phenyl-α-glycolate (phencynonate hydro-chloride, CPG) is a central anticholinergic agent synthesized at the Beijing Institute of Pharmacology and Toxicology. It has been developed as a new medicine for motion sickness. Our previous studies revealed that CPG prevented motion sickness with higher efficacy and lower central inhibitory side effects compared to other motion sickness drugs, such as dimenhydrinate and scopolamine HBr [4] . There is one chiral carbonic atom in the molecular structure of CPG ( Figure 1 ).
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Pharmacological profiles of an anticholinergic agent, phencynonate hydrochloride, and its optical isomers
Thus, there were two optical isomers of CPG with R(-)-and S(+)-different configurations. The pharmacological effects of these isomers remained unknown. In order to study the pharmacological differences between the stereoisomers and develop more safe drugs, we investigated the pharmacological characteristics of these two chiral muscarinic antagonists by comparing their effects on muscarinic receptors in vivo and in vitro. Binding assays on rat cerebral cortex homogenate Male or female Wistar rats were killed by decapitation. The cerebral cortex was immediately removed and processed as described by Yamamura and Snyder [5] . Protein concentration was determined by the method of Lowry et al [6] . Homogenate (50 mg of protein) was incubated for at 37 ºC for 30 min in 0.5 mL of assay buffer containing 6 nmol/L [ 3 H]QNB and various concentrations of drugs. In saturation binding assays, the homogenate was incubated in the presence of The filters were rinsed three times with 3 mL cold buffer, and placed in scintillation vials containing 3 mL of scintillation fluid. Radioactivity trapped on the filters was determined by liquid scintillation spectrometry at approximately 40%-50% efficiency. Carbachol-induced contraction Male guinea pigs were killed by cervical dislocation. The organs required were set up rapidly under 1 g of tension in 20 mL organ baths containing physiological salt solution (PSS), which was kept at 37 ºC and aerated with 5% CO 2 and 95% O 2 . Two-centimeter-long portions of terminal ileum were taken at about 5 cm from the ileum-cecum junction and mounted in PSS at 37 ºC. The composition of PSS was as the following (mmol/L): NaCl (118), NaHCO 3 The concentration was increased in a stepwise manner after the response to the previous concentration had reached a plateau to make concentration-response curve for carbachol. After cumulative concentration-response curves were generated in the absence of any antagonist, the ileum strips were washed several times with PSS and allowed to relax to baseline. After 60 min, the strips were incubated with R(-)-, S(+)-, or CPG for 10-15 min. The concentration-response curves for carbachol were then obtained in the presence of increasing concentrations of different antagonists.
Materials and methods
Chemicals
To assess the potency of the antimuscarinic action, the ratio of the ED 50 values for the carbachol-induced contrac- tions in the presence and in the absence of antagonist were obtained. Schild plots were obtained by plotting logarithmic (dose ratio-1) against the logarithmic molar concentration of the antagonist, and pA 2 values were derived from the Schild plots according to the method described by Arunlakshana and Schild [7] . Effect on sub-threshold hypnotic dose of sodium pentobarbital induced-sleeping Four dosage groups were used for each drug and each group consists of 10 mice of each sex. CPG and its optical isomers were injected intra-peritoneally (ip). Fifteen minutes later, subthreshold hypnotic dose of sodium pentobarbital (30 mg/kg) was applied ip and lossing in the righting reflex was observed as the score to present the central inhibitory effect of the drugs. The ED 50 values of these three drugs were estimated to compare the central inhibitory effect of the indicated agents.
Inhibiting oxotremorine-induced salivation Four dosage groups were used for each compound and each group consisted of 10 mice of each sex. CPG and its optical isomers were applied ip 15 min prior to the use of oxotremorine (3 mg/ kg) subcutaneously (sc). ED 50 values were utilized to evaluate the anti-secretive potencies of above described compounds.
Statistics Binding assay The IC 50 values were obtained from at least three separate experiments performed in triplicate with between 6 and 8 different concentrations of drugs. Hill coefficients and IC 50 values were determined using the ORIGIN6.0 software program and inhibition constants (K i values) were calculated utilizing the Cheng-Prusoff equation [8] .
Functional assay In carbachol induced-contraction, the E max value (the maximum contractile response) was obtained from the maximum stress developed, and the ED 50 value was calculated from a semi-logarithmic plot of the percentage of the maximum response versus drug concentration. Statistical analyses for comparison between groups and between concentration-response curves were performed using analysis of variance (ANOVA). P<0.05 was considered statistically significant. In the experiments for observing the effects of CPG and its optical isomers on salivation and sedation induced by oxotremorine and sodium pentobarbital, ED 50 values were calculated utilizing the Bliss method. Data were shown as mean±SD. -6 mol/L, the difference was not significant (P>0.05). All slopes of the regression lines of Schild plots were close to unity in Figure 3 . The IC 50 value of R(-)-and CPG are shown in Figure 4 . The rank order of pA 2 values was: CPG (6.80)≈R(-)-CPG (6.84) ( Table 1) .
Results
Competitive binding of CPG and its optical isomers to rat central muscarinic acetylcholine receptors
Potentiating the effect of sub-threshold hypnotic dose of sodium pentobarbital Pentobarbital (ip 30 mg/kg) alone did not cause loss in righting reflex in mice (n=50). Pretreatment the effect of sub-threshold hypnotic dose of sodium pentobarbital in a dose-dependent manner ( Table 2 ). The ED 50 value and its 95% confident limits of CPG was 21.06 (18.02-24.10) mg/kg. The isomer with R(-)-and S(+)-configuration did not show any effects on pentobarbital inducedsleeping at the dose from 10.00-29.15 mg/kg. The result suggested that the central depressant effect of CPG was more potent than the other two isomers used separately.
Oxotremorine (sc 3mg/kg) induced an obvious salivation in mice (n=50). Whereas, CPG and its optical isomers showed antagonistic effects on oxotremorine-induced salivation in dose-dependent manner when pre-administered. The ED 50 ±95% LC for CPG, R(-)-, and S(+)-configuration were 1.07±0.15, 1.10±0.28, and 16.69±4.82 mg/kg, respectively, which indicated that CPG was equivalent to R(-)-CPG and more potent than S(+)-CPG in inhibiting glandular secretion (Table 3) . 
Discussion
Motion sickness is a common disease in modern society. The pathogenic mechanism inducing the sickness is not fully understood. However, the etiologic theory that cholinergic hyperfunction of the vestibular system excites the vomiting center and the central cholinergic neuron system plays an important role in the neural mechanism of motion sickness is generally accepted [9, 10] . The anticholinergic agents, such as scopolamine, when used for preventing motion sickness, present some disadvantages at the effective dose, especially the troublesome central inhibitory effect [11] . The new central anticholinergic drug CPG has been widely used in clinic. Animal experiments and clinic research have demonstrated that CPG was more potent and had lesser central inhibitory side effects in the prevention of motion sickness (airsickness and seasickness) than those of central cholinergic drugs, such as scopolamine HCl and dimenhydrinate [12] . There was the same proportion of two enantiomers in the race mixture of CPG. In order to illuminate the pharmacological profiles of its optical isomers, we compared the affinity of CPG and its optical isomers to muscarinic acetylcholine receptors. In the competitive binding assay, it was found that R(-)-CPG inhibited the binding of [ The M 1 and M 3 subtypes are the major muscarinic acetylcholine receptors in the salivary gland and M 3 is reported to be more abundant [13, 14] . Guinea pig ileum smooth muscle is enriched with muscarinic receptors, the majority of which are of the M 2 subtype whereas the remaining minority belongs to the M 3 subtype [15, 16] . The M 1 , M 2 , and M 4 subtypes of mAChRs are the predominant receptors in the CNS [17] . Our experiments were performed in different species and tissue in vivo and in vitro, preferential binding of one isomer to muscarinic subtype receptor may cause differences in pharmacological action. Drug enantiomers have identical properties in an achiral environment, but should be considered as different chemical compounds. This is because they often differ considerably in potency, pharmacological activity, and pharmacokinetic profile, since the modules with which they interact in biological systems are also optically active. Interactions of both isomers may differ at the active sites through which pharmacological action is mediated. For this, there were possible subtype and sterochemical selective mechanisms that account for the different actions and levels of activity of the CPG and its enantiomers. Hence, further studies were necessary to resolve the underlying mechanisms of muscarinic receptor with these compounds. Taken together, the present work demonstrated that R(-)-CPG acted as an active component in racemate and a competitive antagonist to acetylcholine muscarinic receptors, but S(+)-CPG displayed less activities in comparison to R(-)-CPG and its racemate. In contrast to its racemate, both of the enantiomers showed lower central depressant effects.
